Group One Trading’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Group One Trading’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-98,400	Closed	-$2.71M	–	9095
2021 Q2	$2.71M	Sell	98,400 -32,100	-25%	-$631K	﹤0.01%	2325
2021 Q1	$2.15M	Buy	130,500 +83,900	+180%	+$1.91M	﹤0.01%	2384
2020 Q4	$859K	Buy	46,600 +15,900	+52%	+$285K	﹤0.01%	2782
2020 Q3	$418K	Buy	30,700 +29,400	+2,262%	+$453K	﹤0.01%	3003
2020 Q2	$23K	Buy	+1,300	New	+$19.6K	﹤0.01%	4780

Group One Trading's TBIO Position: Q3 2021 in Review

Group One Trading sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 15,321 shares — an estimated $422K sold.

Group One Trading first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $699K in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Group One Trading reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Group One Trading sold 15,321 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $422K.
Group One Trading first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Group One Trading's Translate Bio, Inc. Common Stock position peaked at $699K in Q1 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.